- Beavers CJ, Ambrosy AP, Butler J, et al. Iron deficiency in heart failure: a scientific statement from the Heart Failure society of America. J Card Fail. 2023;29(7):1059–1077. doi:10.1016/j.cardfail.2023.03.025.
- Mhanna M, Sauer M, Alabdouh A, et al. Intravenous iron therapy for patients with iron deficiency and heart failure: a systematic review and meta-analysis of randomized controlled trials. Proc (Bayl Univ Med Cent). 2024;37(3):466–476. doi:10.1080/08998280.2024.2326387.
- Denny RM, Hummel SL. Heart failure medical management in 2020: searching for the right polypharmacy. Circ: Heart Failure. 2020;13(11):e007779. doi:10.1161/CIRCHEARTFAILURE.120.007779.
- Harrington J, Mentz RJ, Rockhold FW, et al. Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial. Am Heart J. 2023;266:25–31. doi:10.1016/j.ahj.2023.08.005.
- Docherty KF, Welsh P, Verma S, et al. Iron deficiency in heart failure and effect of dapagliflozin: findings from DAPA-HF. Circulation. 2022;146(13):980–994. doi:10.1161/CIRCULATIONAHA.122.060511.
- Ponikowski P, Mentz RJ, Hernandez AF, et al. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. Eur Heart J. 2023;44(48):5077–5091. doi:10.1093/eurheartj/ehad586.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 37, 2024 - Issue 3
Reviews
Iron therapy for patients with iron deficiency and heart failure: a treatment strategy that is increasingly opaque
, MD, , MD & 
Amit Alama Division of Cardiology, New York University Grossman School of Medicine, New York University Langone Health, New York, New York, USACorrespondence[email protected]
https://orcid.org/0000-0002-3040-3957
, MDhttps://orcid.org/0000-0002-3040-3957